Joel Greenblatt Ironwood Pharmaceuticals Inc Transaction History
Gotham Asset Management, LLC
- $9.41 Billion
- Q3 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 23,766 shares of IRWD stock, worth $51,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,766
Previous 60,160
60.5%
Holding current value
$51,809
Previous $392,000
75.26%
% of portfolio
0.0%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding IRWD
# of Institutions
232Shares Held
163MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$49.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$48 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$35.7 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$25.6 Million0.13% of portfolio
-
State Street Corp Boston, MA9.92MShares$21.6 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $334M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...